Dunbar GL - Search Results

1

Early cognitive dysfunction in the HD 51 CAG transgenic rat model of Huntington's disease.

Fink KD, Rossignol J, Crane AT, Davis KK, Bavar AM, Dekorver NW, Lowrance SA, Reilly MP, Sandstrom MI, von Hörsten S, Lescaudron L, Dunbar GL. Fink KD, et al. Among authors: dunbar gl. Behav Neurosci. 2012 Jun;126(3):479-87. doi: 10.1037/a0028028. Behav Neurosci. 2012. PMID: 22642889

2

Medial septal lesions in rats produce permanent deficits for strategy selection in a spatial memory task.

Janis LS, Bishop TW, Dunbar GL. Janis LS, et al. Among authors: dunbar gl. Behav Neurosci. 1994 Oct;108(5):892-8. doi: 10.1037//0735-7044.108.5.892. Behav Neurosci. 1994. PMID: 7826512

3

Comparison of GM1 ganglioside, AGF2, and D-amphetamine as treatments for spatial reversal and place learning deficits following lesions of the neostriatum.

Dunbar GL, Lescaudron LL, Stein DG. Dunbar GL, et al. Behav Brain Res. 1993 Mar 31;54(1):67-79. doi: 10.1016/0166-4328(93)90049-v. Behav Brain Res. 1993. PMID: 8504013

4

Autologous adult bone marrow stem cell transplantation in an animal model of huntington's disease: behavioral and morphological outcomes.

Lescaudron L, Unni D, Dunbar GL. Lescaudron L, et al. Among authors: dunbar gl. Int J Neurosci. 2003 Jul;113(7):945-56. doi: 10.1080/00207450390207759. Int J Neurosci. 2003. PMID: 12881187

5

Neurotrophic enhancers as therapy for behavioral deficits in rodent models of Huntington's disease: use of gangliosides, substituted pyrimidines, and mesenchymal stem cells.

Dunbar GL, Sandstrom MI, Rossignol J, Lescaudron L. Dunbar GL, et al. Behav Cogn Neurosci Rev. 2006 Jun;5(2):63-79. doi: 10.1177/1534582306289367. Behav Cogn Neurosci Rev. 2006. PMID: 16801683 Review.

6

Effects of intensity and type of prepulse stimulus on prepulse inhibition in scopolamine treated rats.

Andrus AK, Marable BR, Dunbar GL, Reilly MP, Maurissen JP. Andrus AK, et al. Among authors: dunbar gl. Pharmacol Biochem Behav. 2007 Oct;87(4):481-8. doi: 10.1016/j.pbb.2007.06.004. Epub 2007 Jun 23. Pharmacol Biochem Behav. 2007. PMID: 17669478

7

The novel substituted pyrimidine, KP544, reduces motor deficits in the R6/2 transgenic mouse model of Huntington's disease.

Dey ND, Boersen AJ, Myers RA, York LR, Bombard MC, Lu M, Sandstrom MI, Hulce VD, Lescaudron L, Dunbar GL. Dey ND, et al. Among authors: dunbar gl. Restor Neurol Neurosci. 2007;25(5-6):485-92. Restor Neurol Neurosci. 2007. PMID: 18334766

8

7-nitroindazole attenuates 6-hydroxydopamine-induced spatial learning deficits and dopamine neuron loss in a presymptomatic animal model of Parkinson's disease.

Haik KL, Shear DA, Hargrove C, Patton J, Mazei-Robison M, Sandstrom MI, Dunbar GL. Haik KL, et al. Among authors: dunbar gl. Exp Clin Psychopharmacol. 2008 Apr;16(2):178-89. doi: 10.1037/1064-1297.16.2.178. Exp Clin Psychopharmacol. 2008. PMID: 18489022

9

Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's disease.

Dey ND, Bombard MC, Roland BP, Davidson S, Lu M, Rossignol J, Sandstrom MI, Skeel RL, Lescaudron L, Dunbar GL. Dey ND, et al. Among authors: dunbar gl. Behav Brain Res. 2010 Dec 25;214(2):193-200. doi: 10.1016/j.bbr.2010.05.023. Epub 2010 May 21. Behav Brain Res. 2010. PMID: 20493905

10

Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington's disease: morphological and behavioral outcomes.

Rossignol J, Boyer C, Lévèque X, Fink KD, Thinard R, Blanchard F, Dunbar GL, Lescaudron L. Rossignol J, et al. Among authors: dunbar gl. Behav Brain Res. 2011 Mar 1;217(2):369-78. doi: 10.1016/j.bbr.2010.11.006. Epub 2010 Nov 9. Behav Brain Res. 2011. PMID: 21070819

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters